The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Hyperkalemia Market: A BCC Research Perspective
US$ 2,500.00
The goals of this study were to understand the current market scenario for hyperkalemia drugs and to assess the market’s growth potential through the end of 2022. This study explores market dynamics...
January 2020
19 pages
Investigation Report on Chinese Pregabalin Market, 2020-2024
US$ 2,200.00
... prospect in China. Topics Covered: Development environment of Chinese Pregabalin market Governmental approval of Pregabalin in China Prices of Pregabalin in China Major Pregabalin manufacturers in China Factors influencing the development of Chinese Pregabalin market Prospects of Chinese Pregabalin market
January 2020
30 pages
Anti-Rheumatics Market by Drug Class (Disease Modifying Anti-Rheumatic Drugs (DMARD's), Nonsteroidal Anti-Inflammatory Drugs (NSAID's), Corticosteroids, Uric Acid Drugs, and Others), Type (Prescription-Based Drugs and Over-the-Counter Drugs): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026. Rheumatoid arthritis (RA) is a c...
January 2020
202 pages
Immunosuppressants Market by Drug class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, and Others), Indication (Organ Transplantation, Autoimmune Disorders, and Non-Autoimmune Inflammatory Diseases), and Distribution channel (Hospital pharmacies, Retail pharmacies and Online pharmacies): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global immunosuppressants market was valued at $13,890.0 million in 2018 and is expected to reach $42,511.37 million by 2026, registering a CAGR of 14.7% from 2019 to 2026. Immunosuppressants supp...
January 2020
165 pages
Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global antihypertensive market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026. Antihypertensive drugs are emp...
December 2019
222 pages
Antihyperlipidemic Drugs Market by Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, and Combination): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global antihyperlipidemic drugs market accounted for $9,456 million in 2018, and is expected to reach $16,864 million by 2026, registering a CAGR of 7.5% from 2019 to 2026. Lipids are defined as t...
December 2019
184 pages
Antifibrinolytic Drugs Market by Indication (Gynecology, Hereditary Angiedema, Fibrinolytic Response Testing, Surgeries, and Others) and End user (Hospitals & Clinics, Ambulatory Surgical Centers, and Healthcare Specialty Process): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global antifibrinolytic drugs market was valued at $1,3593 million in 2018 and is expected to reach $1,9333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026. Antifibrinolytic is a typ...
December 2019
165 pages
2020 Worldwide Pharmacies & Drug Stores Industry-Industry & Market Report
US$ 299.00
The 2019 Worldwide Pharmacies & Drug Stores Industry-Industry & Market ... well as the proprietary 2019 Worldwide Economic Forecast executive summary. The report features 2019 current and 2020 ... and estimates on up to 10 sub-industries, including pharmacies and proprietary stores. Barnes Reports' Industry & Market ...
December 2019
140 pages
Global Botanical and plant-derived drugs market Size study, by source (Plant, Algae, Macroscopic fungi) By dosage form (Pills, Tablets, Capsules, Injection) By Therapeutic applications (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases) and Regional Forecasts 2019-2026
US$ 3,750.00
Global Botanical and plant-derived drugs market is valued approximately at USD 31.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.10% over the forecast period 20...
December 2019
200 pages
Abdominal Aortic Aneurysms - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Abdominal Aortic Aneurysms - Pipeline Review-2019 provides an overview of the pipeline landscape of Abdominal Aortic Aneurysms It provides comprehensive insights of all the clinica...
December 2019
100 pages
Actinic Keratosis - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Actinic Keratosis - Pipeline Review-2019 provides an overview of the pipeline landscape of Actinic Keratosis It provides comprehensive insights of all the clinical and non-clinical...
December 2019
120 pages
Acute Ischemic Stroke - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Acute Ischemic Stroke - Pipeline Review-2019 provides an overview of the pipeline landscape of Acute Ischemic Stroke It provides comprehensive insights of all the clinical and non-...
December 2019
130 pages
Acute Lung Injury - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Acute Lung Injury - Pipeline Review-2019 provides an overview of the pipeline landscape of Acute Lung Injury It provides comprehensive insights of all the clinical and non-clinical...
December 2019
100 pages
Acute Pain - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Acute Pain - Pipeline Review-2019 provides an overview of the pipeline landscape of Acute Pain It provides comprehensive insights of all the clinical and non-clinical therapeutics...
December 2019
130 pages
Adrenoleukodystrophy - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Adrenoleukodystrophy - Pipeline Review-2019 provides an overview of the pipeline landscape of Adrenoleukodystrophy It provides comprehensive insights of all the clinical and non-cl...
December 2019
120 pages
AIDS Related Cancer - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's AIDS Related Cancer - Pipeline Review-2019 provides an overview of the pipeline landscape of AIDS Related Cancer It provides comprehensive insights of all the clinical and non-clin...
December 2019
130 pages
AlphaMannosidosis - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's AlphaMannosidosis - Pipeline Review-2019 provides an overview of the pipeline landscape of AlphaMannosidosis It provides comprehensive insights of all the clinical and non-clinical...
December 2019
100 pages
Alport Syndrome - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Alport Syndrome - Pipeline Review-2019 provides an overview of the pipeline landscape of Alport Syndrome It provides comprehensive insights of all the clinical and non-clinical the...
December 2019
130 pages
Alstrom Syndrome - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Alstrom Syndrome - Pipeline Review-2019 provides an overview of the pipeline landscape of Alstrom Syndrome It provides comprehensive insights of all the clinical and non-clinical t...
December 2019
120 pages
Aneurysmal Subarachnoid Hemorrhage - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Aneurysmal Subarachnoid Hemorrhage - Pipeline Review-2019 provides an overview of the pipeline landscape of Aneurysmal Subarachnoid Hemorrhage It provides comprehensive insights of...
December 2019
130 pages
Angelman Syndrome - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Angelman Syndrome - Pipeline Review-2019 provides an overview of the pipeline landscape of Angelman Syndrome It provides comprehensive insights of all the clinical and non-clinical...
December 2019
130 pages
AnorexiaCachexia Syndrome - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's AnorexiaCachexia Syndrome - Pipeline Review-2019 provides an overview of the pipeline landscape of AnorexiaCachexia Syndrome It provides comprehensive insights of all the clinical...
December 2019
130 pages
Anterior Uveitis - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Anterior Uveitis - Pipeline Review-2019 provides an overview of the pipeline landscape of Anterior Uveitis It provides comprehensive insights of all the clinical and non-clinical t...
December 2019
130 pages
Aplastic anemia - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Aplastic anemia - Pipeline Review-2019 provides an overview of the pipeline landscape of Aplastic anemiaIt provides comprehensive insights of all the clinical and non-clinical ther...
December 2019
120 pages
Arterial Thrombosis - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Arterial Thrombosis - Pipeline Review-2019 provides an overview of the pipeline landscape of Arterial ThrombosisIt provides comprehensive insights of all the clinical and non-clini...
December 2019
130 pages
Astrocytoma - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Astrocytoma - Pipeline Review-2019 provides an overview of the pipeline landscape of Astrocytoma It provides comprehensive insights of all the clinical and non-clinical therapeutic...
December 2019
100 pages
Atrial Fibrillation - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Atrial Fibrillation - Pipeline Review-2019 provides an overview of the pipeline landscape of Atrial Fibrillation It provides comprehensive insights of all the clinical and non-clin...
December 2019
130 pages
Autism Spectrum Disorder - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Autism Spectrum Disorder - Pipeline Review-2019 provides an overview of the pipeline landscape of Autism Spectrum Disorder It provides comprehensive insights of all the clinical an...
December 2019
120 pages
Autoimmune Hepatitis - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Autoimmune Hepatitis - Pipeline Review-2019 provides an overview of the pipeline landscape of Autoimmune Hepatitis It provides comprehensive insights of all the clinical and non-cl...
December 2019
130 pages
Axial Spondyloarthritis - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Axial Spondyloarthritis - Pipeline Review-2019 provides an overview of the pipeline landscape of Axial SpondyloarthritisIt provides comprehensive insights of all the clinical and n...
December 2019
130 pages
Barth Syndrome - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Barth Syndrome - Pipeline Review-2019 provides an overview of the pipeline landscape of Barth Syndrome It provides comprehensive insights of all the clinical and non-clinical thera...
December 2019
130 pages
Becker Muscular Dystrophy - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Becker Muscular Dystrophy - Pipeline Review-2019 provides an overview of the pipeline landscape of Becker Muscular Dystrophy It provides comprehensive insights of all the clinical...
December 2019
130 pages
Biliary Tumor - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Biliary Tumor - Pipeline Review-2019 provides an overview of the pipeline landscape of Biliary Tumor It provides comprehensive insights of all the clinical and non-clinical therape...
December 2019
120 pages
Bone Marrow Transplant Rejection - Pipeline Review - 2019
US$ 1,250.00
Firstview Insight's Bone Marrow Transplant Rejection - Pipeline Review-2019 provides an overview of the pipeline landscape of Bone Marrow Transplant Rejection It provides comprehensive insights of all...
December 2019
130 pages
